GPS-68636-52576
4 vaccinations
6 coded responses
54 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 113 / NY
- Registered
- 2021-01-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-19
Dose 1 — Pfizer-BioNTech
-
2021-01-20
Registered in v-safe
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-02-02
- 2021-02-09
- 2021-02-16
-
2021-02-21
Dose 2 — Pfizer-BioNTech
- 2021-02-21
-
2021-02-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Fatigue or tirednessAdult check-in
- 2021-02-23
- 2021-02-24
- 2021-02-25
- 2021-02-26
- 2021-02-27
- 2021-02-28
- 2021-03-07
- 2021-03-14
- 2021-03-21
- 2021-03-28
- 2021-04-04
- 2021-05-23
- 2021-08-22
-
2021-10-15
Dose 3 — Pfizer-BioNTech
- 2021-10-15
- 2021-10-16
- 2021-10-17
- 2021-10-18
- 2021-10-19
- 2021-10-20
- 2021-10-21
- 2021-10-22
- 2021-10-29
- 2021-11-05
- 2021-11-12
- 2021-11-19
- 2021-11-26
-
2022-01-14
Survey response — 3 months, dose 3MedDRA: Arthralgia, Cough, Night sweats, Respiratory tract congestion, Sneezing — Feeling: FairFree text: cough, congestion, joint aches, night sweats, sneezingMedDRA releases: 2024-11 · check-in free text available
-
2022-04-15
Survey response — 6 months, dose 3MedDRA: Chills, Cough, Fatigue, Food poisoning, Nasopharyngitis, Nausea, Pyrexia, Respiratory tract congestion, Vomiting — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: cold - cough/congestion food poisoning - fever, fatigue, chills, nausea, vomitingMedDRA releases: 2024-11 · check-in free text available
-
2022-04-15
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
- 2022-04-19
-
2022-10-15
Survey response — 12 months, dose 3MedDRA: COVID-19, Fungal infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: covid, yeast infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-11-30
Dose 4 — Pfizer-BioNTech
- 2022-11-30
-
2022-12-01
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-12-02
- 2022-12-03
- 2022-12-04
- 2022-12-05
- 2022-12-06
- 2022-12-07
- 2022-12-14
- 2022-12-21
-
2022-12-28
Survey response — day 28, dose 4MedDRA: Fatigue, Feeling hot, Headache, Thirst — Feeling: Fair · Be unable to do your normal daily activitiesFree text: headache, fatigue, thirst, feeling overheatedMedDRA releases: 2024-11 · check-in free text available
- 2023-01-04
- 2023-01-11
-
2023-03-01
Survey response — 3 months, dose 4MedDRA: Headache, Respiratory tract congestion, Sneezing — Feeling: GoodMedDRA releases: 2024-11
-
2023-05-31
Survey response — 6 months, dose 4MedDRA: Cough, Lacrimation increased, Respiratory tract congestion, Sneezing — Feeling: FairMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-19 | Pfizer-BioNTech | |
| 2 | 2021-02-21 | Pfizer-BioNTech | |
| 3 | 2021-10-15 | Pfizer-BioNTech | No |
| 4 | 2022-11-30 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 10 — 3 months, dose 3
Symptoms: cough, congestion, joint aches, night sweats, sneezing
Release 11 — 6 months, dose 3
Symptoms: cold - cough/congestion food poisoning - fever, fatigue, chills, nausea, vomiting
Release 12 — 12 months, dose 3
Symptoms: covid, yeast infection
Release 12 — day 28, dose 4
Symptoms: headache, fatigue, thirst, feeling overheated
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Feeling hot | · | · | ✓ |
| SD | Food poisoning | · | · | ✓ |
| SD | Fungal infection | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Lacrimation increased | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Night sweats | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SD | Thirst | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release